Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment

Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment

Colorectal cancer (CRC) is one of the most common tumors worldwide, with a higher rate of distant metastases than other malignancies and with regular occurrence of drug resistance. Therefore, scientists are forced to further develop novel and innovative therapeutic treatment strategies, whereby it h...

Full description

Bibliographic Details
Main Authors:	Anna-Lena Mueller, Aranka Brockmueller, Niusha Fahimi, Tahere Ghotbi, Sara Hashemi, Sadaf Sadri, Negar Khorshidi, Ajaikumar B. Kunnumakkara, Mehdi Shakibaei
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Biomedicines
Subjects:	colorectal cancer biotherapeutical toxins bacteriocins bacterial peptides bacteriotherapy microbiota
Online Access:	https://www.mdpi.com/2227-9059/10/4/832

Similar Items

Colorectal cancer treatment using bacteria: focus on molecular mechanisms
by: Sara Ebrahimzadeh, et al.
Published: (2021-07-01)

Calebin A, a Compound of Turmeric, Down-Regulates Inflammation in Tenocytes by NF-κB/Scleraxis Signaling
by: Anna-Lena Mueller, et al.
Published: (2022-02-01)

Modulation of Inflammation by Plant-Derived Nutraceuticals in Tendinitis
by: Anna-Lena Mueller, et al.
Published: (2022-05-01)

Calebin A targets the HIF-1α/NF-κB pathway to suppress colorectal cancer cell migration
by: Aranka Brockmueller, et al.
Published: (2023-07-01)

Nisin E Is a Novel Nisin Variant Produced by Multiple <i>Streptococcus equinus</i> Strains
by: Ivan Sugrue, et al.
Published: (2023-02-01)

Bacteriocins From LAB and Other Alternative Approaches for the Control of Clostridium and Clostridiodes Related Gastrointestinal Colitis
by: Svetoslav D. Todorov, et al.
Published: (2020-09-01)

Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment
by: Aranka Brockmueller, et al.
Published: (2023-03-01)

Multifunctionality of Calebin A in inflammation, chronic diseases and cancer
by: Aranka Brockmueller, et al.
Published: (2022-09-01)

Effect of a bacteriocin-producing Streptococcus salivarius on the pathogen Fusobacterium nucleatum in a model of the human distal colon
by: Garreth W. Lawrence, et al.
Published: (2022-12-01)

Evidence That Tumor Microenvironment Initiates Epithelial-To-Mesenchymal Transition and Calebin A can Suppress it in Colorectal Cancer Cells
by: Constanze Buhrmann, et al.
Published: (2021-07-01)

Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacy
by: Sara Manti, et al.
Published: (2020-04-01)

Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin
by: Marcin Mielecki, et al.
Published: (2022-08-01)

BIOFILM AND TUMOR: INTERPRETATION OF INTERACTION AND TREATMENT STRATEGIES. Review
by: N. Ivanenko
Published: (2021-03-01)

Postbiotics and Their Health Modulatory Biomolecules
by: Emma Scott, et al.
Published: (2022-11-01)

β1-Integrin plays a major role in resveratrol-mediated anti-invasion effects in the CRC microenvironment
by: Aranka Brockmueller, et al.
Published: (2022-09-01)

Evolutionary Stabilization of Cooperative Toxin Production through a Bacterium-Plasmid-Phage Interplay
by: Stefanie Spriewald, et al.
Published: (2020-08-01)

Alginate-Based Patch for Middle Ear Delivery of Probiotics: A Preliminary Study Using Electrospray and Electrospinning
by: Beatrice Cecchini, et al.
Published: (2023-11-01)

Hydrogels as promising platforms for engineered living bacteria-mediated therapeutic systems
by: Shuangjiang Yu, et al.
Published: (2022-12-01)

Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
by: Mansour Sedighi, et al.
Published: (2019-06-01)

Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
by: Giancarlo Ceccarelli, et al.
Published: (2021-01-01)

Fecal microbiota transplantation in puppies with canine parvovirus infection
by: Giorgio Q. Pereira, et al.
Published: (2018-03-01)

Efficacy of Probiotic, Chlorhexidine, and Sodium Fluoride Mouthrinses on Mutans Streptococci in 8- to 12-Year-Old Children: A Crossover Randomized Trial
by: Krutika Y. Gedam, et al.
Published: (2022-01-01)

Resveratrol Suppresses Cross-Talk between Colorectal Cancer Cells and Stromal Cells in Multicellular Tumor Microenvironment: A Bridge between In Vitro and In Vivo Tumor Microenvironment Study
by: Constanze Buhrmann, et al.
Published: (2020-09-01)

Occurrence and potential mechanism of holin-mediated non-lytic protein translocation in bacteria
by: Thomas Brüser, et al.
Published: (2022-10-01)

Challenges and Strategies for a Thorough Characterization of Antibody Acidic Charge Variants
by: Y. Diana Liu, et al.
Published: (2022-11-01)

Recovery of Fecal Microbiome and Bile Acids in Healthy Dogs after Tylosin Administration with and without Fecal Microbiota Transplantation
by: Margaux Marclay, et al.
Published: (2022-06-01)

Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the “HPVinHIV” Trial
by: Eugenio Nelson Cavallari, et al.
Published: (2021-11-01)

Advances in the Study of Lactic Acid Bacteria as Vehicles for the In Vivo Delivery of Bioactive Substances
by: CHEN Yunhui, XIA Yongjun, SONG Xin, AI Lianzhong, WANG Guangqiang
Published: (2023-07-01)

Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes
by: Federica Perillo, et al.
Published: (2020-07-01)

Curcumin Attenuates Environment-Derived Osteoarthritis by Sox9/NF-kB Signaling Axis
by: Constanze Buhrmann, et al.
Published: (2021-07-01)

Evidence That β1-Integrin Is Required for the Anti-Viability and Anti-Proliferative Effect of Resveratrol in CRC Cells
by: Aranka Brockmueller, et al.
Published: (2022-04-01)

Microbiome Therapeutics for Food Allergy
by: Diana A. Chernikova, et al.
Published: (2022-12-01)

Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent <i>Clostridioides difficile</i> Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study
by: Frederik Cold, et al.
Published: (2022-01-01)

Infected chronic ischemic wound topically treated with a multi-strain probiotic formulation: a novel tailored treatment strategy
by: Salvatore Venosi, et al.
Published: (2019-11-01)

p28 Bacterial Peptide, as an Anticancer Agent
by: Atieh Yaghoubi, et al.
Published: (2020-08-01)

IgY Antibodies as Biotherapeutics in Biomedicine
by: Diana León-Núñez, et al.
Published: (2022-09-01)

Biotherapeutics and its applications in Microbiology
by: Navjot Kaur, et al.
Published: (2021-03-01)

In vitro adhesion, pilus expression, and in vivo amelioration of antibiotic-induced microbiota disturbance by Bifidobacterium spp. strains from fecal donors
by: Aki Ronkainen, et al.
Published: (2023-12-01)

Group A streptococcal collagen-like protein 1 restricts tumor growth in murine pancreatic adenocarcinoma and inhibits cancer-promoting neutrophil extracellular traps
by: Emily A. Henderson, et al.
Published: (2024-03-01)

Relationship between Human Papillomavirus Status and the Cervicovaginal Microbiome in Cervical Cancer
by: Hong Duc Thi Nguyen, et al.
Published: (2023-05-01)